[Elsevier] Effect of the Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Evolocumab on Glycemia, Body Weight, and New-Onset Diabetes Mellitus

Mos272 Post time 2024-5-4 19:02:55 | Show all posts |Read mode
Reward10points

journal£ºThe American Journal of Cardiology

Authors£ºNaveed Sattar; Peter P. Toth; Dirk J. Blom; Michael J. Koren; Handrean Soran; Magdalena Uhart; Mary Elliott; Marcoli Cyrille; Ransi Somaratne; David Preiss

Published date£º2017-11-

DOI£º10.1016/j.amjcard.2017.07.047

PDF link£ºhttps://www.sciencedirect.com/sc ... 002914917312201/pdf

Article link£ºhttp://dx.doi.org/10.1016/j.amjcard.2017.07.047

Article Source£ºElsevier BV¡£


Remark£º

Best Answer

Please adopt

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
AradDeh Post time 2024-5-4 19:02:56 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    100

Latest Reply

Return to the list